Evaluation of eligibility criteria in advanced prostate cancer clinical trials based on ASCO-FCR recommendations.

被引：0
|
作者：
Feng, Matthew I.
Prajapati, Sweta R.
Castro, Daniela V.
Lee, Kyle O.
Chan, Elyse H.
Sehgal, Ishaan
Patel, Jalen
O'Dell, Anna
Zengin, Zeynep Busra
Li, Xiaochen
Chehrazi-Raffle, Alex
Dizman, Nazli
Tripathi, Abhishek
Rock, Adam
Liu, Sandy
Mercier, Benjamin D.
Meza, Luis A.
Philip, Errol James
Dorff, Tanya B.
Pal, Sumanta Monty
机构：
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] City Hope Comprehens Canc Ctr, Duarte, CA USA
[3] Yale Univ, Sch Med, New Haven, CT USA
[4] City Hope Comprehens Canc Ctr, Dept Med Oncol & Expt Therapeut, Duarte, CA USA
[5] City Hope Orange Country Lennar Fdn Canc Ctr, Irvine, CA USA
[6] Univ Calif San Francisco, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
34
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Assessment of eligibility criteria in advanced urothelial cancer (aUC) trials based on ASCO-FCR recommendations.
    Castro, Daniela V.
    Feng, Matthew I.
    Prajapati, Sweta R.
    Chan, Elyse H.
    Lee, Kyle O.
    Sehgal, Ishaan
    Patel, Jalen
    O'Dell, Anna
    Zengin, Zeynep Busra
    Li, Xiaochen
    Chehrazi-Raffle, Alex
    Dizman, Nazli
    Tripathi, Abhishek
    Rock, Adam
    Liu, Sandy
    Mercier, Benjamin D.
    Meza, Luis A.
    Philip, Errol James
    Dorff, Tanya B.
    Pal, Sumanta Monty
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [2] Evaluation of eligibility criteria in contemporary renal cell carcinoma based on ASCO-FCR recommendations.
    Prajapati, Sweta R.
    Feng, Matthew I.
    Castro, Daniela V.
    Lee, Kyle O.
    Chan, Elyse H.
    Sehgal, Ishaan
    Patel, Jalen
    O'Dell, Anna
    Zengin, Zeynep Busra
    Li, Xiaochen
    Chehrazi-Raffle, Alex
    Dizman, Nazli
    Rock, Adam
    Liu, Sandy
    Meza, Luis A.
    Philip, Errol James
    Dorff, Tanya B.
    Pal, Sumanta Monty
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [3] Eligibility criteria requirements and adherence in advanced prostate cancer trials
    Wong, Sarah
    Sweeney, Christopher
    Sridhar, Srikala S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [4] Reappraisal of eligibility criteria in cancer clinical trials
    Penel, Nicolas
    Lebellec, Loic
    Vanseymortier, Marie
    CURRENT OPINION IN ONCOLOGY, 2018, 30 (05) : 352 - 357
  • [5] Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria
    Bonomi, Philip
    Blumenthal, Gideon
    Ferris, Andrea Stern
    Stewart, David J.
    Selig, Wendy K. D.
    Krug, Lee M.
    Allen, Jeff
    Ison, Gwynn
    Langer, Corey J.
    Melemed, Allen
    Odogwu, Lauretta
    Roy, Upal Basu
    Sandler, Alan
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (06) : 748 - 751
  • [6] Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion
    Mercier, Benjamin D.
    Govindarajan, Ameish
    Castro, Daniela V.
    Li, Xiaochen
    Philip, Errol J.
    Feng, Matthew I.
    Prajapati, Sweta R.
    Chan, Elyse H.
    Lee, Kyle O.
    Sehgal, Ishaan
    Patel, Jalen
    O'Dell, Anna
    Chehrazi-Raffle, Alexander
    Ebrahimi, Hedyeh
    Rock, Adam
    Zengin, Zeynep Busra
    Meza, Luis A.
    Dizman, Nazli
    Hsu, Joann
    Liu, Sandy
    Dorff, Tanya B.
    Pal, Sumanta K.
    Tripathi, Abhishek
    CANCER MEDICINE, 2025, 14 (07):
  • [7] Recommendations for Broadening Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials
    Siegel, Corey A.
    Rai, Victoria
    Outtier, An
    Vermeire, Severine
    Law, Cindy C. W.
    Sands, Bruce E.
    Abdulhamid, Asim
    Gearry, Richard
    McGuire, Josh
    Lindsay, James O.
    Panaccione, Remo
    Schweistein, Hagai
    Dotan, Iris
    Scarallo, Luca
    Griffiths, Anne
    Dubinsky, Marla C.
    JOURNAL OF CROHNS & COLITIS, 2024,
  • [8] Reducing patient eligibility criteria in cancer clinical trials
    George, SL
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1364 - 1370
  • [9] Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Prior Therapies Work Group
    Osarogiagbon, Raymond U.
    Vega, Diana Merino
    Fashoyin-Aje, Lola
    Wedam, Suparna
    Ison, Gwynn
    Atienza, Sol
    De Porre, Peter
    Biswas, Tithi
    Holloway, Jamie N.
    Hong, David S.
    Wempe, Madison M.
    Schilsky, Richard L.
    Kim, Edward S.
    Wade, James L., III
    CLINICAL CANCER RESEARCH, 2021, 27 (09) : 2408 - 2415
  • [10] Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group
    Magnuson, Allison
    Bruinooge, Suanna S.
    Singh, Harpreet
    Wilner, Keith D.
    Jalal, Shadia
    Lichtman, Stuart M.
    Kluetz, Paul G.
    Lyman, Gary H.
    Klepin, Heidi D.
    Fleury, Mark E.
    Hirsch, Brad
    Melemed, Allen
    Arnaldez, Fernanda, I
    Roy, Upal Basu
    Schenkel, Caroline
    Sherwood, Shimere
    Garrett-Mayer, Elizabeth
    CLINICAL CANCER RESEARCH, 2021, 27 (09) : 2424 - 2429
12345